Evofem Inc.
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (NCT04553068) | Evofem Inc. | 2020-10-15 |
| Phase 2B/3 Double-blinded Placebo-controlled (NCT03107377) | Evofem Inc. | 2017-11-03 |
Track Evofem Inc. automatically
Every clearance here is in the API, with alerts when new ones post.